1.DJ-1 gene and Parkinson disease
Jing-Hong MA ; Hai-Qiang ZOU ; Biao CHEN ;
Basic & Clinical Medicine 2006;0(01):-
Recently,more and more attention have been focused on the role of genetics in the pathogenesis of Parkinson disease.DJ1 gene is a newly discovered gene related to Parkinson disease.Here,the structure,tissue location and pathological properties of the DJ-1 Protein are reviewed.The DJ1 mutant protein and its association with early onset and sporadic Parkinson disease are also discussed in the review.
2.Time resolved fluoroimmunoassay for Glypican 3 and its preliminary application
Dan, LI ; Jing, ZHANG ; Xin, BAI ; Biao, HUANG ; Yi, ZHANG ; Zhong-wei, L(U) ; Hong, TU
Chinese Journal of Nuclear Medicine 2011;31(3):201-204
Objective To establish a time resolved fluoroimmunoassay (TRFIA) method for detecting Glypican 3 (GPC3) and to explore the diagnostic value of serum GPC3 for hepatic carcinoma (HCC). Methods Microplate coated with anti-GPC3 monoclonal antibody 7C8 and GP9 labeled with Eu3+ were used to establish TRFIA kit. The serum concentrations of GPC3 in 41 HCC patients and 44 chronic hepatitis (CH) patients were quantitatively analyzed. AFP was detected by with lowest limit of 2.06 μg/L. The CV of inter and intra assay were 12.25% and 12.91%, respectively. The average serum concentration of GPC3 in HCC patients was (86.68±110.39) μg/L (median: 56.98 μg/L). But in CH patients it was only (14.77±29.48) μg/L, which was significantly lower than that in HCC (Wilcoxon W=1335.00, Z=-4.99, P<0.001). With diagnostic cut-off value set at 42.94 μg/L, the diagnostic sensitivity and specificity of TRFIA GPC3 for HCC were 58.5% (24/41) and 95.5%(42/44) respectively. The diagnostic sensitivity of AFP was 46.3% (19/41) in 41 HCC patients, and was raised to 78.0% (32/41) when combined with GPC3. Conclusions Serum GPC3 assay by TRFIA is established and it could increase the diagnostic sensitivity for HCC when combined with AFP.
3.Diagnosis and treatment of 11 cases with sinonasal neuroendocrine carcinoma.
Guo-hong QIAN ; Jin-biao SHANG ; Ke-jing WANG ; Zhuo TAN
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2011;46(12):1033-1035
OBJECTIVETo explore the diagnosis and treatment and prognosis of sinonasal neuroendocrine carcinoma.
METHODSThe clinical data of 11 cases with sinonasal neuroendocrine carcinoma treated in Zhejiang Cancer Hospital from 1998 to 2010 were analyzed retrospectively. Ten cases were small cell type and one case was atypical carcinoid. One case by only operation, one case by only radiotherapy, one case by only chemotherapy, two cases by radiotherapy and chemotherapy, 6 cases by combined treatment based on surgery (surgery combined with radiotherapy and chemotherapy).
RESULTSAll cases have been followed up for 2 months to 12 years. Six cases by combined treatment one case died in 3 years and one case died in 4 years after treatment, one case has survived without tumor for 12 years and two cases have survived without tumor for 8 years, one case was still in treatment. Five cases of other treatment programs, four cases died in 12 months, one case died in 18 months.
CONCLUSIONSThere's no standard treatment plan. Combined treatment based on surgery should be adopted to nasal neuroendocrine carcinoma. Reccurrence is frequent and the prognosis is poor. The key to improving the survival rate of the disease is early accurate diagnosis and combined treatment.
Adult ; Aged ; Carcinoma, Neuroendocrine ; diagnosis ; therapy ; Combined Modality Therapy ; Female ; Humans ; Male ; Middle Aged ; Nose Neoplasms ; diagnosis ; therapy ; Paranasal Sinus Neoplasms ; diagnosis ; therapy ; Prognosis ; Retrospective Studies
4.Prevalence of non-motor symptoms in 440 patients with Parkinson ' s disease and their correlative factors
Jing-Hong MA ; Hai-Qiang ZOU ; Fei SUN ; Jing AN ; Biao CHEN
Chinese Journal of Neuromedicine 2012;11(12):1225-1228
Objective To investigate the prevalence of non-motor symptoms in patients with Parkinson disease (PD) and their impact factors.Methods The detailed clinical information (onset age and disease duration) of 440 patients with idiopathic PD,admitted to our hospital from 2008 to 2011,were recorded.Several scales,including non-motor symptom screening scale,Hamilton depression rating scale (HAMD) and unified Parkinson's disease rating scale(UPDRS),were performed; these data were calculated with SPSS statistic software.Results Among the 440 PD patients,defecation incompletion (60.5%) and constipation (60%) enjoyed the highest frequency,followed by forgetfulness (56.6%),sweating (52%) and sadness (47.7%).Spearman rank correlation analysis showed that the sum of non-motor symptoms had a linear positive correlation with disease durations,HAMD total scores,and UPDRS Ⅱ and Ⅲ scores (P<0.05).The frequency of daytime dribbling,taste/smelling abnormality,swallowing difficulty or choking,and constipation in patients with different disease durations were significantly different (P<0.05); however,the frequency of forgetfulness,concentration and sadness in patients with different disease durations showed no significant differences (P>0.05).Conclusion Gastrointestinal and psychiatric symptoms,and memory loss are the most common non-motor symptoms in PD patients; the sum of the non-motor symptoms increases with the increment of disease durations and the severity of PD and depression.
5.Epidemiological characteristics of obesity and its relation to chronic diseases among middle aged and elderly men
Hong-Lan LI ; Biao XU ; Wei ZHENG ; Wang-Hong XU ; Jing GAO ; Xiao-Ou SHU ; Yong-Bing XIANG
Chinese Journal of Epidemiology 2010;31(4):370-374
Objective To investigate the epidemiological characteristics of obesity and how they related to chronic diseases among middle aged and elderly men in urban Shanghai.Methods A cross-sectional analysis was conducted using data from a baseline survey from an on-going cohort study of 61 500 men between 40-74 of age in urban Shanghai.Study subjects were recruited from 8 communities of an urban district in Shanghai during 2002 to 2006.General obesity was measured by body mass index (BMI≥28) and,central obesity by waist to hip ratio (WHR≥0.9).Unconditional logistic regression model was used to estimate the odds ratio and 95% confidence interval of chronic diseases associated with obesity after adjustment for potential confounding factors.Results The aged-adjusted prevalence rates of overweight,overall obesity and central obesity were 36.8%,7.7% and 49.7% respectively.In this population,66.7% subjects had ever been diagnosed with one or more kinds of chronic diseases,in which hypertension ranked first with an age-adjusted prevalence rate of 26.5%.After mutual adjustment for WHR and BMI,obesity (BMI≥28) appeared to be associated with increased prevalence rates of hypertension,coronary heart disease,gallstone,urinary tract calculus and stroke comparing to men having normal BMI (18.5≤BMI<24) with ORs ranged from 1.16 to 3.13.However,to the lowest quartile,the ORs associated with the highest WHR were between 1.20 and 1.69 for these 5 diseases.All P values for trend tests were less than 0.05.WHR was positively associated with diabetes,with OR as 2.40 (95% CI:2.14-2.70) for the highest quartile comparing to the lowest quartile.BMI was unrelated to the diabetes prevalence.Prevalence of chronic obstructive pulmonary disease decreased with increasing BMI,but increased with WHR.The corresponding OR was 0.87 (95% CI:0.77-0.98)for the obese men compared to those with normal BMI while 1.26(95%CI:1.14-1.40) for the subjects with the highest WHR comparing to those with the lowest WHR.Conclusion The prevalence rates of hypertension,gallstone,urinary tract calculus,cardiovascular and cerebrovascular diseases were higher in obesity men.Central obesity seemed to be related to high prevalence of diabetes.
6.A preliminary study about the apoptostic mechanism of RNA targeting basic fibroblast growth factor in glioma U251 cells.
Jing-chao WU ; Xue-quan FENG ; Jin-huan WANG ; Jun LIU ; Biao ZHANG ; Xin-nü XU ; Hong-sheng LIU
Chinese Journal of Surgery 2012;50(10):928-932
OBJECTIVETo preliminarily investigate the mechanism of small interfering RNA (siRNA) induced apoptosis in glioma U251 cells by silencing basic fibroblast growth factor (bFGF).
METHODSU251 cells were divided into the normal control group, the mock group and experiment group, the mock and experiment group were transfected with mock vector (Ad-null) and the recombinant adenovirus carrying bFGF-siRNA (Ad-bFGF-siRNA) respectively at a multiplicity of infection (MOI) of 100. After 72 hours, the expression of related proteins was revealed by the method of Western blot. Mitochondrial transmembrane potential (ΔΨm) was measured with flow cytometry and confocal microscopy, Groups were compared using single factor analysis of variance (One-way ANOVA).
RESULTSAfter U251 cells were transfected with bFGF-siRNA, the results of Western blot showed that after 72 hours of transfection the bFGF protein in the experiment group decreased obviously, meanwhile Cytochrome C, Caspase-3 and Bax showed increased expression while in the Bcl-xl and Bcl-2 proteins decreased expression. The proportion of high mitochondrial membrane potential of cells by flow cytometry, the experimental group was 74.4% ± 4.7% decreased significantly compared with the control group 92.1% ± 2.5%, the mock group 90.9% ± 1.8% (F = 28.805, P < 0.05); laser scanning confocal microscopy results showed that the red fluorescence and green fluorescence ratio of the experimental group was 0.83 ± 0.12 decreased significantly compared with 1.36 ± 0.40 of the control group and 1.32 ± 0.35 of the mock group(F = 7.920, P < 0.05).
CONCLUSIONsiRNA targeting bFGF induced U251 cell apoptosis may be achieved through the mitochondrial pathway.
Adenoviridae ; genetics ; Apoptosis ; Cell Line, Tumor ; Fibroblast Growth Factor 2 ; genetics ; Glioma ; pathology ; Humans ; RNA Interference ; RNA, Small Interfering ; Transfection
7.A clinical study of flap necrosis protection with dexamethasone.
Jing-min CAO ; Biao WANG ; Kai-hua LU ; Yan HAN ; Shu-zhong GUO ; Yu-hong LANG ; Ling CHEN
Chinese Journal of Plastic Surgery 2003;19(6):433-435
OBJECTIVEThis clinical study was to find an effective method to prevent flap from necrosis.
METHODSWhen a flap showed blood flow problems, dexamethasone of 0.3 mg/kg was given intravenously for 2 days. Then the dose was decreased to 0.2 mg/kg at the third and the fourth day. At the fifth and the sixth day, dexamethasone of 0.1 mg/kg was given.
RESULTSA total of 51 flaps with blood flow problems was treated with this method. Thirty of them recovered completely; 18 survived mostly and 3 failed.
CONCLUSIONEarly application of dexamethasone can effectively ameliorate blood flow problems of the flap.
Adolescent ; Adult ; Dexamethasone ; pharmacology ; therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Necrosis ; Surgical Flaps ; pathology
8.Radiosensitivity of nasopharyngeal carcinoma in relation to cell cycle synchronization effect of tumor necrosis factor alpha.
Jian YUAN ; Ning SUN ; Li-jing WANG ; Wei TIAN ; Xiao-ming ZHOU ; Dong-bo CHEN ; Hong-biao GU
Journal of Southern Medical University 2007;27(3):374-376
OBJECTIVETo investigate the effect of tumor necrosis factor alpha (TNFalpha) on radiosensitivity of nasopharyngeal carcinoma (NPC) in relation to TNFalpha-induced cell cycle synchronization.
METHODSThe radio-resistance of a NPC cell line subclone CNE-2Z-S1 was verified by in vivo experiments and flow cytometry was performed to evaluate cell cycle synchronization in TNFalpha-treated CNE-2Z-S1 cells. The radiosensitivity of the cell synchronized CNE-2Z-S1 cells was determined by clone formation in vitro and in vivo experiment in nude mice.
RESULTSTNFalpha was capable of inducing cell cycle arrest and synchronization of CNE-2Z-S1 cells. Pretreatment with TNFalpha remarkably enhanced the radiosensitivity of CNE-2Z-S1 in vitro, and in vivo experiments with nude mice also suggested the role of TNFalpha in enhancing the radiosensitivity of NPC.
CONCLUSIONTNFalpha can enhance the radiosensitivity of NPC cells by inducing cell cycle synchronization.
Animals ; Cell Cycle ; drug effects ; radiation effects ; Cell Line, Tumor ; Humans ; Mice ; Mice, Nude ; Nasopharyngeal Neoplasms ; drug therapy ; pathology ; radiotherapy ; Radiation-Sensitizing Agents ; pharmacology ; Tumor Necrosis Factor-alpha ; pharmacology ; Xenograft Model Antitumor Assays
9.Protective effect of lycopene on human spermatozoa during cryopreservation and its mechanism.
Zuo-wen LIANG ; Kai-min GUO ; Xiao-fan DAI ; Ling-yun LIU ; Sheng-qi XU ; Li-jing ZHAO ; Fu-biao LI ; Hong-liang WANG
National Journal of Andrology 2015;21(6):521-526
OBJECTIVETo investigate the protective effect of lycopene against cryopreservation injury of post-thawing human sperm and its mechanism.
METHODSSemen samples were collected from 25 volunteers, each sample equally divided into four parts to be cryopreserved with cryoprotectant only (Ly0 control) or cryoprotectant + lycopene at the concentrations of 2 (Ly2), 5 (Ly5), and 10 µmol/L (Ly10), respectively. Before and after thawing, the semen samples were subjected to computer-assisted semen analysis ( CASA) for sperm kinematics, flow cytometry for sperm apoptosis, thiobarbituric acid assay for malondialdehyde (MDA) concentration, and JC-1 fluorescent staining for the sperm mitochondrial membrane potential (MMP).
RESULTSAfter cryopreservation, sperm motility was markedly decreased in all the groups (P < 0.01). The rate of sperm apoptosis was significantly lower in the Ly5 group than in the Ly0 control ([25.68 ± 4.36]% vs [33.26 ± 4.78]%, P < 0.05), while sperm MMP remarkably higher in the former than in the latter ([66.18 ± 14.23]% vs [55.24 ± 12.31]%, P < 0.05). The Ly2, Ly5 and Ly10 groups showed no statistically significance differences in the MDA level from the Ly0 control (P > 0.05).
CONCLUSIONAddition of lycopene at a proper concentration to cryoprotectant may reduce oxidative damage to sperm mitochondria in the freezing-thawing process, attenuate oxidative stress injury induced by reactive oxygen species to sperm plasma membrane, and improve the anti-apoptosis ability of sperm.
Apoptosis ; Carotenoids ; pharmacology ; Cryopreservation ; Cryoprotective Agents ; pharmacology ; Flow Cytometry ; Humans ; Male ; Malondialdehyde ; analysis ; Oxidative Stress ; Reactive Oxygen Species ; Semen Analysis ; Semen Preservation ; adverse effects ; methods ; Sperm Motility ; Spermatozoa ; drug effects ; physiology
10.Proteomics research of bufalin-induced apoptosis in osteosarcoma cell lines.
Xian-Biao XIE ; Li-Li WEN ; Jun-Qiang YIN ; Hong-Yi LIAO ; Chang-Ye ZOU ; Bo WANG ; Gang HUANG ; Jing-Nan SHEN
China Journal of Chinese Materia Medica 2014;39(14):2739-2743
OBJECTIVETo study the apoptosis inducing effects of bufalin on various human osteosarcoma cells and the concerning molecular mechanisms.
METHODMTT assay was used to detect the growth inhibition rates of osteosarcoma cells U-20S, U-20S/MTX300, SaOS-2, IOR/OS9 treated with bufalin in different concentrations and times. The apoptosis of cells was observed flow cytometry 48 h following bufalin treatment. The proteomic techniques were used to separate and compare the treated and control groups 48 h after bufalin-incubation. Then, the proteomic results were validated by western blot.
RESULTBufalin inhibited the growth of human osteosarcoma cells U20S, U20S/MTX300 (methotrexate resistant cells), SAOS2, IOR/OS9 in a dose- and time-dependent manner. The 72 h IC50 were (37.43 +/- 4.1), (32.24 +/- 5.3) nmol x L(-1) in U20S,U20S/MTX300 cells,respectivly. Flow cytometry showed that the apoptosis cells were increased following bufalin treatment. The protein expression profile showed 24 differentiated expression proteins. Among these proteins, the level of an anti-apoptotic protein, heat shock protein 27 (Hsp27) decreased significantly and the result was then validated by western blot. Ectopic expression of Hsp27 could reduce the bufalin-induced apoptosis remarkably in U20S and U20S/MTX300 cells.
CONCLUSIONBufalin could inhibit the cell growth and induce apoptosis on human osteosarcoma cells. The effect of bufalin may be related to the joint intervention with multiple protein targets. Among them, downregulation of Hsp27 plays a critical role in the bufalin-induced apoptosis in human osteosarcoma cells.
Antineoplastic Agents ; pharmacology ; Apoptosis ; drug effects ; Bufanolides ; pharmacology ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Gene Expression Regulation, Neoplastic ; drug effects ; Humans ; Osteosarcoma ; pathology ; Proteomics